Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHM Teabag for Stroke Risk Reduction in Elderly
NCT05801575Unknown
- Sponsor
- Hong Kong Baptist University
- Start
- Feb 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of Elix Cycle Balance in stroke (4 arms), sponsored by Hong Kong Baptist University. Primary endpoint: Stroke risk estimated with Automatic Retinal Image Analysis at 16 weeks. Status: unknown.
02
Drugs
Elix Cycle Balance
03
Conditions
stroke
Beyond the preview
Go deeper on NCT05801575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05801575.